Copy

January 29, 2021                                                           View this email in your browser

Spring Senior Executives Meeting Goes Virtual in May

This May, the ALDA Senior Executive Conference is going virtual. The focus and theme for the event is appropriately “Pandemics and Infectious Disease,” and ALDA members will convene to hear insights from experts, network, and discuss strategic implications for our member companies.
 
Registration information with final dates, times, and speakers will go out to members in February. We are planning to structure the event similarly to our fall conference, holding one session per week over the course of several weeks in May. We are finalizing speakers and topics and are very excited about the compelling narrative that will flow through the event. Current sessions and speakers include (but are not limited to):
  • Analytical Retrospective on COVID-19 and Infectious Disease. Presented by Dr. Pardis Sabeti with the Broad Institute, a professor in the Department of Immunology and Infectious Disease at the Harvard School of Public Health who led the original team that genetically sequenced the Ebola Virus and has been a leader in scientific breakthroughs aimed at stopping the spread of COVID-19.
  • The Future of Vaccine Development. Attendees will hear from companies that developed approved vaccines, who will share their perspective on COVID vaccine acceleration and rollout and how ALDA members can continue to contribute to similar efforts moving forward. 
  • The COVID-19 Vaccines: Implications for Other Infectious Diseases. Dr. Penny Heaton, CEO of the Bill & Melinda Gates Medical Research Institute will discuss their collaborative efforts on battling infectious disease including tuberculosis & malaria and how the pandemic reaction and accelerated vaccine development will impact these efforts moving forward.
  • Policy Perspective: What did we learn regarding how various international governing bodies approached this pandemic? How did they engage industry, and how can we position ourselves for better collaboration and communication in the future?
     
  • CEO Roundtable: What does this all mean for the ALDA community? What has our industry learned and how can we build on these lessons moving forward? A panel of prominent industry CEOs will answer these and other relevant questions, as determined by attendees.
ALDA Welcomes New Board Member
 

Puneet Sarin
ALDA is pleased to welcome new board member Puneet Sarin, President of BD Biosciences. In his role, Mr. Sarin is responsible for driving the global strategic, operational and commercial performance across BD Biosciences while advancing the innovation pipeline, associate engagement, and customer experience for the business. Mr. Sarin was nominated by the ALDA Nominations Committee and ratified by the ALDA Board of Directors.
 
Mr. Sarin joins the board as his former colleague Patrick Kaltenbach has left BD and will be stepping into the role of CEO for Mettler-Toledo effective April 1. We are very excited for Patrick to be taking on this prominent position. Patrick has agreed to stay on the ALDA Board as Chair-Elect and step into the position of ALDA Chair this coming October.
Diversity & Inclusion Benchmarking Survey Results Coming Soon
 
Thank you to everyone who participated in the first annual ALDA D&I Benchmarking Survey! We had participation from over 40 ALDA member companies representing ~300,000 employees worldwide. The resulting report will be shared with participants in the coming weeks; more to come.
Save the Date: D&I Results Webinar on February 22 at 11:00 AM Eastern
 
Speaking of the D&I survey, our partners from Pearl Meyer will walk through the D&I survey findings during a live webinar on Monday, February 22. This webinar is for participants only and registration information will be shared along with the final report. The session will be recorded for those who can’t attend live.
LinkedIn LinkedIn
ALDA Website ALDA Website
ALDA Welcomes Back Halo Labs
 

Halo Labs
(formerly Optofluidics) is located in Burlingame, California, and is a scientific instrumentation and consumable company that commercializes high-throughput biopharmaceutical formulation and quality control tools for particle analysis using state-of-the-art custom optics and image processing techniques.
 
Rick Gordon, CEO, will be the official representative to ALDA, and Bernardo Cordovez, CSO, will be the alternate representative.
 
For more information about the company, their products and services, please visit their website at www.halolabs.com.
Save the Date: Marketing & Sales Executive Conference
 
ALDA member sales & marketing executives will convene virtually on Thursday, March 18 at 11:00 AM Eastern for the annual ALDA Marketing & Sales Executives Conference. This year’s event will focus on sales and marketing communication in the new/now normal, with a heavy emphasis placed on the necessitated pivot to digital and the long-term impact on our industry. Attendees will hear from customers, industry experts, and each other regarding the latest trends and what’s next.
 
Thursday, March 18
11:00 AM – 1:00 PM Eastern US

Tentative Schedule:
11:00–11:50 AM:
Customer panel moderated by Bill Kelly from Bioinformatics.
11:50 AM-12:30 PM:
Hot topics session presented by Matt Greenstein with the Alexander Group
12:30–1:00 PM:
Networking via breakout rooms. Rooms will be pre-assigned with hot topics selected during the registration process.
 
Registration will be coming soon; watch your inboxes. A reminder that ALDA membership is a corporate membership; any individuals from your company who would find this content valuable can attend, free of charge.
Thank you for your continued support of ALDA.
Copyright © 2021 Analytical, Life Science & Diagnostics Association (ALDA), All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp